Tom Pepper

Thomas Pepper is a seasoned professional in clinical development and operations, currently serving as Chief Executive and Director of Clinical Development at PTEN Research since August 2019, where the focus is on advancing research for PTEN Hamartoma Syndrome. Previously, Thomas held the position of Director of Clinical Operations at Alnylam Pharmaceuticals, overseeing multiple global programmes in rare diseases and cardiovascular areas from July 2017 to August 2019. A significant portion of Thomas's career was spent at Roche Pharmaceuticals, culminating as Senior Clinical Program Leader for Oncology, with responsibilities spanning from early-stage drug development to operational delivery for the oncology portfolio. Thomas's experience includes roles at Antisoma and GlaxoSmithKline, along with foundational positions at Roche Pharmaceuticals, and education includes a BSc (Hons) in Natural Sciences from Durham University.